Literature DB >> 1315369

Temperature enhancement of syncytium formation by HIV and Sendai virus.

D Kinchington1, W Barker, S Galpin, K Apostolov.   

Abstract

Syncytium formation, the characteristic cytopathic effect (CPE) of the human immunodeficiency virus (HIV) and cell fusion by Sendai virus, is accelerated by increasing the ambient temperature to values at which normal metabolic activity is inhibited. Uninfected C8166, CEM, and H9 cells were absorbed at 4 degrees C onto monolayers of H9 cells chronically infected with HIV and incubated subsequently at either 37 degrees C or 45 degrees C. Similarly chick and human erythrocytes and Hela cells were agglutinated with Sendai virus at 4 degrees C before incubation at temperatures of up to 50 degrees C. With both viruses the rate of cell fusion was directly related to temperature. Since membrane fluidity is dependent on the phase-transition temperature points of the membrane lipids it is proposed that sufficient membrane fluidity is essential for cell fusion to occur. The implication of these observations on the cytopathology of HIV is discussed.

Entities:  

Mesh:

Year:  1992        PMID: 1315369     DOI: 10.1002/jmv.1890360109

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  3 in total

1.  Unique morphological alterations of the HTLV-I transformed C8166 cells by infection with HIV-1.

Authors:  J Ongrádi; H M Laird; J F Szilágyi; A Horváth; M Bendinelli
Journal:  Pathol Oncol Res       Date:  2000       Impact factor: 3.201

2.  Feline immunodeficiency virus decreases cell-cell communication and mitochondrial membrane potential.

Authors:  I R Danave; E Tiffany-Castiglioni; E Zenger; R Barhoumi; R C Burghardt; E W Collisson
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

3.  Physicochemical dissociation of CD4-mediated syncytium formation and shedding of human immunodeficiency virus type 1 gp120.

Authors:  Y K Fu; T K Hart; Z L Jonak; P J Bugelski
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.